IO Biotech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -214 | -211 | ||
EBITDA | -26,724 | -26,299 | -21,319 | -19,986 |
EBIT | -26,943 | -26,504 | -21,533 | -20,197 |
Net Income | -31,333 | -24,015 | -20,686 | -19,457 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,636 | -20,818 | -16,994 | -24,943 |
Cash | 60,031 | 80,185 | 100,747 | 117,982 |
Basic Shares | 65,880 | 65,880 | 65,880 | 65,880 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -756 | -540 | ||
EBITDA | -95,177 | -91,228 | -69,343 | -67,450 |
EBIT | -91,443 | -69,883 | -67,452 | |
Net Income | -95,491 | -86,083 | -71,458 | -67,879 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -60,419 | |||
Free Cash Flow | -82,391 | -72,060 | -60,419 | -40,799 |
Cash | 60,031 | 143,193 | 142,590 | 211,531 |
Basic Shares | 65,880 | 43,539 | 28,815 | 28,815 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.45 |
2024-09-30 | -$0.34 |
2024-06-30 | -$0.28 |
2024-03-31 | -$0.30 |
